• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颅内动脉瘤破裂。病例发病率和死亡率。

Ruptured intracranial aneurysms. Case morbidity and mortality.

作者信息

Post K D, Flamm E S, Goodgold A, Ransohoff J

出版信息

J Neurosurg. 1977 Mar;46(3):290-5. doi: 10.3171/jns.1977.46.3.0290.

DOI:10.3171/jns.1977.46.3.0290
PMID:839254
Abstract

The authors review 100 consecutive cases of ruptured intracranial aneurysms to assess the overall morbidity and mortality. Patients were placed on a regimen of bed rest, sedation, control of blood pressure, anticonvulsants, and antifibrinolytic therapy. Surgery was performed on 86 patients with hypotensive anesthesia and microsurgical techniques. The incidence of early rebleeding while on epsilon aminocaproic acid and control of blood pressure was 11.8%. The overall surgical mortality was 8.1%, and the surgical mortality of patients in Grades 1, 2, and 3 was 6.3%. Of the 100 patients, 60 were able to return to their prior activities, and 25 had moderate neurological deficits that required limitation of their activities. The total case mortality was 15%. The evidence presented indicates that the regimen of active medical treatment before microsurgical intervention has improved the overall case morbidity and mortality, as well as the chance for long-term survival.

摘要

作者回顾了100例连续性颅内动脉瘤破裂病例,以评估总体发病率和死亡率。患者接受了卧床休息、镇静、血压控制、抗惊厥药物和抗纤维蛋白溶解治疗的方案。86例患者采用低血压麻醉和显微外科技术进行了手术。在使用氨甲环酸和血压控制期间,早期再出血的发生率为11.8%。总体手术死亡率为8.1%,1、2和3级患者的手术死亡率为6.3%。100例患者中,60例能够恢复到之前的活动水平,25例有中度神经功能缺损,需要限制活动。总病例死亡率为15%。所提供的证据表明,显微外科干预前的积极药物治疗方案改善了总体病例的发病率和死亡率,以及长期生存的机会。

相似文献

1
Ruptured intracranial aneurysms. Case morbidity and mortality.颅内动脉瘤破裂。病例发病率和死亡率。
J Neurosurg. 1977 Mar;46(3):290-5. doi: 10.3171/jns.1977.46.3.0290.
2
Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy.在早期动脉瘤手术前降低再出血风险:抗纤溶治疗的潜在作用。
J Neurosurg. 1997 Feb;86(2):220-5. doi: 10.3171/jns.1997.86.2.0220.
3
The long-term outcome in patients with multiple aneurysms. Incidence of late hemorrhage and implications for treatment of incidental aneurysms.
J Neurosurg. 1983 Oct;59(4):642-51. doi: 10.3171/jns.1983.59.4.0642.
4
Endovascular embolization vs surgical clipping in treatment of cerebral aneurysms: morbidity and mortality with short-term outcome.血管内栓塞术与外科夹闭术治疗脑动脉瘤的比较:发病率、死亡率及短期预后
Surg Neurol. 2006 Sep;66(3):277-84; discussion 284. doi: 10.1016/j.surneu.2005.12.031.
5
Formal protocol for emergency treatment of ruptured intracranial aneurysms to reduce in-hospital rebleeding and improve clinical outcomes.降低颅内动脉瘤破裂患者院内再出血率并改善临床结局的急诊治疗正式方案。
J Neurosurg. 2015 Feb;122(2):383-91. doi: 10.3171/2014.9.JNS131784. Epub 2014 Nov 18.
6
[Effectiveness of antifibrinolytic, edema-preventing and hypotensive agents in the prevention of recurrent bleeding from intracranial aneurysms].[抗纤溶、预防水肿及降压药物在预防颅内动脉瘤再出血中的有效性]
Neurol Neurochir Pol. 1979 Nov-Dec;13(6):647-51.
7
Review of the management of saccular aneurysms.囊状动脉瘤的治疗综述
Neurol Clin. 1983 Feb;1(1):73-86.
8
Risk of bleeding from unruptured aneurysm in cases with multiple intracranial aneurysms.
J Neurosurg. 1981 Oct;55(4):524-6. doi: 10.3171/jns.1981.55.4.0524.
9
Distal anterior cerebral artery aneurysms: treatment and outcome analysis of 501 patients.大脑前动脉远端动脉瘤:501例患者的治疗及结果分析
Neurosurgery. 2008 Mar;62(3):590-601; discussion 590-601. doi: 10.1227/01.neu.0000317307.16332.03.
10
Clinical signs pointing to the source of hemorrhage in multiple intracranial aneurysms.提示多发性颅内动脉瘤出血来源的临床体征。
Med Sci Monit. 2002 Feb;8(2):CR83-6.

引用本文的文献

1
Comparison between ruptured anterior choroidal artery aneurysms and ruptured intracranial aneurysms in other locations in relation to aneurysm dimensions at rupture.破裂的脉络膜前动脉动脉瘤与其他部位破裂的颅内动脉瘤在破裂时动脉瘤大小方面的比较。
Acta Neurochir (Wien). 2025 Jan 13;167(1):12. doi: 10.1007/s00701-025-06425-7.
2
The Role of Computed Tomographic Angiography in Predicting the Development of Vasospasm Following Ruptured Intracranial Aneurysm Microsurgery.计算机断层血管造影在预测颅内动脉瘤破裂显微手术后血管痉挛发生中的作用
Cureus. 2023 Sep 16;15(9):e45386. doi: 10.7759/cureus.45386. eCollection 2023 Sep.
3
Unruptured cerebral aneurysm risk stratification: Background, current research, and future directions in aneurysm assessment.
未破裂脑动脉瘤的风险分层:动脉瘤评估的背景、当前研究及未来方向
Surg Neurol Int. 2022 Apr 29;13:182. doi: 10.25259/SNI_1112_2021. eCollection 2022.
4
Study on early re-rupture of intracranial aneurysms.
Acta Neurochir (Wien). 1996;138(1):12-8. doi: 10.1007/BF01411717.
5
Surgical mortality in an aneurysm population: effects of age, blood pressure and preoperative neurological state.动脉瘤患者的手术死亡率:年龄、血压及术前神经状态的影响。
J Neurol Neurosurg Psychiatry. 1980 Oct;43(10):879-82. doi: 10.1136/jnnp.43.10.879.
6
Anti-fibrinolytic treatment in the pre-operative management of subarachnoid haemorrhage caused by ruptured intracranial aneurysm.颅内动脉瘤破裂所致蛛网膜下腔出血术前管理中的抗纤维蛋白溶解治疗
J Neurol Neurosurg Psychiatry. 1981 Mar;44(3):220-6. doi: 10.1136/jnnp.44.3.220.
7
Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).动脉瘤性蛛网膜下腔出血后血液和脑脊液中的凝血与纤溶:氨甲环酸(AMCA)的作用
Acta Neurochir (Wien). 1981;56(1-2):25-38. doi: 10.1007/BF01400969.
8
Symptomatic unruptured giant aneurysms: medical treatment.有症状的未破裂巨大动脉瘤:药物治疗
Acta Neurochir (Wien). 1982;62(3-4):207-18. doi: 10.1007/BF01403626.
9
Antifibrinolytic treatment in subarachnoid haemorrhage: present state.蛛网膜下腔出血的抗纤溶治疗:现状
Acta Neurochir (Wien). 1982;63(1-4):233-44. doi: 10.1007/BF01728877.
10
Prediction of cerebral vasospasm value of fibrinogen degradation products (FDP) in the cerebro-spinal fluid (CSF) for prediction of vasospasm following subarachnoid haemorrhage due to a ruptured aneurysm.预测脑脊液(CSF)中纤维蛋白原降解产物(FDP)对破裂动脉瘤所致蛛网膜下腔出血后血管痉挛的预测价值。
Acta Neurochir (Wien). 1984;73(1-2):25-33. doi: 10.1007/BF01401781.